Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lineage Commitment01:21

Lineage Commitment

4.6K
Commitment is the  process whereby stem cells:
4.6K
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

2.3K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.3K
Histone Modification02:32

Histone Modification

17.3K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
17.3K
Histone Modification02:32

Histone Modification

5.0K
5.0K
Inheritance of Chromatin Structures03:17

Inheritance of Chromatin Structures

7.9K
Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying...
7.9K
Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

10.0K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
10.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RP5-833A20.1/miR-382-5p/NFIA-dependent signal transduction pathway contributes to the regulation of cholesterol homeostasis and inflammatory reaction.

Arteriosclerosis, thrombosis, and vascular biology·2014
Same author

Nur77 decreases atherosclerosis progression in apoE(-/-) mice fed a high-fat/high-cholesterol diet.

PloS one·2014
Same author

A lincRNA-DYNLRB2-2/GPR119/GLP-1R/ABCA1-dependent signal transduction pathway is essential for the regulation of cholesterol homeostasis.

Journal of lipid research·2014
Same author

Dihydrocapsaicin Attenuates Plaque Formation through a PPARγ/LXRα Pathway in apoE(-/-) Mice Fed a High-Fat/High-Cholesterol Diet.

PloS one·2013
Same author

[Progress of Niemann-Pick type C1 Like 1 on cholesterol metabolism].

Sheng li xue bao : [Acta physiologica Sinica]·2012
Same author

Cruciate ligament reconstruction using LARS artificial ligament under arthroscopy: 81 cases report.

Chinese medical journal·2010

Related Experiment Video

Updated: Apr 8, 2026

Epigenetic Regulation of Cardiac Differentiation of Embryonic Stem Cells and Tissues
13:03

Epigenetic Regulation of Cardiac Differentiation of Embryonic Stem Cells and Tissues

Published on: June 3, 2016

8.7K

Histone deacetylases and cardiovascular cell lineage commitment.

Jun-Yao Yang1, Qian Wang1, Wen Wang1

  • 1Jun-Yao Yang, Qian Wang, Laboratory Medicine Centre, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong Province, China.

World Journal of Stem Cells
|July 2, 2015
PubMed
Summary

Histone deacetylases (HDACs) regulate genes involved in cardiovascular diseases. This review explores how HDACs and their inhibitors impact stem cell differentiation for potential cardiovascular therapies.

Keywords:
Cardiovascular diseasesEndothelial cellHistone deacetylasesSmooth muscle cellStem cell

More Related Videos

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

9.0K
Efficient Derivation of Human Cardiac Precursors and Cardiomyocytes from Pluripotent Human Embryonic Stem Cells with Small Molecule Induction
10:46

Efficient Derivation of Human Cardiac Precursors and Cardiomyocytes from Pluripotent Human Embryonic Stem Cells with Small Molecule Induction

Published on: November 3, 2011

20.8K

Related Experiment Videos

Last Updated: Apr 8, 2026

Epigenetic Regulation of Cardiac Differentiation of Embryonic Stem Cells and Tissues
13:03

Epigenetic Regulation of Cardiac Differentiation of Embryonic Stem Cells and Tissues

Published on: June 3, 2016

8.7K
Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

9.0K
Efficient Derivation of Human Cardiac Precursors and Cardiomyocytes from Pluripotent Human Embryonic Stem Cells with Small Molecule Induction
10:46

Efficient Derivation of Human Cardiac Precursors and Cardiomyocytes from Pluripotent Human Embryonic Stem Cells with Small Molecule Induction

Published on: November 3, 2011

20.8K

Area of Science:

  • Cardiovascular biology
  • Epigenetics
  • Stem cell therapy

Background:

  • Cardiovascular diseases (CVDs) are a leading global cause of death, linked to inflammation, lipid disorders, and endothelial dysfunction.
  • Stem cell therapy is emerging as a promising treatment for CVDs, aiming to regenerate damaged heart and vascular tissues.
  • Histone deacetylases (HDACs) are epigenetic regulators crucial for biological processes, including cardiovascular health, by influencing vascular cell homeostasis.

Purpose of the Study:

  • To review the roles of various HDACs in cardiovascular diseases.
  • To examine the impact of HDAC inhibitors on stem/progenitor cell differentiation into vascular lineages.
  • To discuss the therapeutic potential of targeting HDACs in CVD treatment.

Main Methods:

  • Literature review focusing on HDACs, stem cells, and cardiovascular disease.
  • Analysis of studies investigating HDACs' function in endothelial cells, smooth muscle cells, and cardiomyocytes.
  • Exploration of research on HDAC inhibitors' effects on stem cell differentiation.

Main Results:

  • HDACs play critical roles in modulating vascular cell proliferation, migration, and apoptosis.
  • HDACs influence stem and progenitor cell differentiation towards endothelial cells, smooth muscle cells, and cardiomyocytes.
  • HDAC inhibitors show potential in directing stem cell differentiation for cardiovascular regeneration.

Conclusions:

  • HDACs are significant epigenetic regulators in cardiovascular pathophysiology.
  • Targeting HDACs offers a novel therapeutic strategy for CVDs by leveraging stem cell differentiation.
  • Further research into HDAC inhibitors could unlock new avenues for regenerative cardiovascular medicine.